ROIV:NASDAQ, Roivant Sciences Ltd.
ROIV stock overview
Roivant Sciences Ltd. (ROIV:NASDAQ) closed at $39.53 on November 13, 2026,
down 1.15% on the day.
The stock trades 7.0% below its 52-week high of $42.50
and 98.0% above its 52-week low of $19.96.
Over the past year, it gained 92.3%.
Roivant Sciences Ltd. is part of the Health Care sector.
Key figures
- Price
- $39.53
- Day change
- -1.15%
- Volume
- 7,194,650
- Average volume
- 8,079,345
- Market cap
- 28B+
- 52-week range
- $19.96 – $42.50
- 50-day average
- $37.20
- 200-day average
- $32.22
Price action over the past year
In 252 trading sessions since November 13, 2025, ROIV closed higher on 126 days (50%).
Its best day was February 6, 2026 (+22.14%) and its worst was August 28, 2026 (-7.64%).
The stock moved 10% or more in a single session 3 times.
It opened at least 5% above the previous day's high 3 times.
Recent signals
ROIV news
-
Nov 12, 2026:
How Trial Wins And Drug Launch Revenue Will Impact Roivant Sciences Stock (ROIV)
-
Nov 10, 2026:
Priovant Announces Publication of Phase 2 BEACON Results for Brepocitinib in Cutaneous Sarcoidosis in JAMA Dermatology
-
Nov 10, 2026:
Roivant Sciences Ltd (ROIV) (Q2 2026) Earnings Call Highlights: LISRIA Launch Delivers $31 ...
-
Nov 9, 2026:
Roivant Sciences (ROIV) Q2 2026 Earnings Call Transcript
-
Nov 9, 2026:
Roivant Sciences Q2 Earnings Call Highlights
-
Nov 9, 2026:
Roivant Beats As LISRAYA Launch Lands At $31 Million, But Stocking And An Unsettled RA Path Complicate A Breakout Quarter
-
Nov 9, 2026:
Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Tops Revenue Estimates
-
Nov 9, 2026:
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended September 30, 2026
About Roivant Sciences Ltd.
Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients.
Similar stocks
Find more stocks like ROIV with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.